|
ARSENIC HEALTH EFFECTS RESEARCH PROGRAM |
|
PROJECTS |
|
APPENDICES |
|
Berkeley |
|
University of California |
|
Table S2. Odds Ratios of Type 2 Diabetes Mellitus and Urine Arsenic Concentrations: |
|
|
||||||||||
|
Odds Ratios of Type 2 Diabetes Mellitus and Urine Arsenic Concentrations Including Results Adjusted for Urine Creatinine |
||||||||||||
|
|
|
No. |
|
|
Unadjusted |
|
|
Adjusteda |
|
|
Adjustedb |
|
|
|
|
Cases |
Control |
|
OR |
95% CI |
|
OR |
95% CI |
|
OR |
95% CI |
|
Total Arsenic |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
£20th percentile (£3.5 µg/L) |
21 |
141 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
≥80th percentile (≥18.3 µg/L) |
17 |
142 |
|
0.8 |
0.41-1.59 |
|
0.88 |
0.39-1.97 |
|
0.9 |
0.35-2.34 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lower tertile (£5.2 µg/L) |
36 |
232 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
Middle tertile (5.3-11.8 µg/L) |
32 |
230 |
|
0.9 |
0.54-1.49 |
|
0.87 |
0.48-1.55 |
|
0.87 |
0.47-1.61 |
|
|
Upper tertile (>11.8 µg/L) |
30 |
235 |
|
0.82 |
0.49-1.38 |
|
0.76 |
0.42-1.39 |
|
0.76 |
0.37-1.56 |
|
Arsenobetaine |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Below detectionc (£0.3 µg/L) |
42 |
217 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
≥80th percentile (≥6.2 µg/L) |
15 |
142 |
|
0.55 |
0.29-1.02 |
|
0.59 |
0.29-1.19 |
|
0.59 |
0.29-1.22 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lower tertile (£0.3 µg/L) |
42 |
217 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
Middle (0.4-2.2 µg/L) |
29 |
246 |
|
0.61 |
0.37-1.01 |
|
0.68 |
0.38-1.21 |
|
0.68 |
0.38-1.22 |
|
|
Upper (>2.2 µg/L) |
27 |
234 |
|
0.6 |
0.36-1.00 |
|
0.62 |
0.34-1.13 |
|
0.62 |
0.34-1.15 |
|
Estimated Inorganic Arsenic |
|
|
|
|
|
|
|
|
|
|
||
|
|
£20th percentile (£2.7 µg/L) |
20 |
142 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
≥80th percentile (≥11.9 µg/L) |
22 |
139 |
|
1.12 |
0.59-2.15 |
|
1.15 |
0.53-2.50 |
|
1.4 |
0.53-3.69 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lower tertile (£4.1 µg/L) |
36 |
227 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
Middle tertile (4.2-8.5 µg/L) |
29 |
238 |
|
0.77 |
0.46-1.30 |
|
0.63 |
0.34-1.15 |
|
0.67 |
0.35-1.29 |
|
|
Upper tertile (>8.5 µg/L) |
33 |
232 |
|
0.9 |
0.54-1.49 |
|
0.98 |
0.53-1.80 |
|
1.13 |
0.52-2.48 |
|
Dimethylarsonic acid (DMA) |
|
|
|
|
|
|
|
|
|
|
||
|
|
£20th percentile (£1.9 µg/L)d |
15 |
111 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
≥80th percentile (≥7.0 µg/L) |
21 |
146 |
|
1.06 |
0.53-2.16 |
|
1.05 |
0.45-2.44 |
|
1.13 |
0.42-3.07 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Lower tertile (£2.7 µg/L) |
35 |
227 |
|
1 |
ref |
|
1 |
ref |
|
1 |
ref |
|
|
Middle tertile (2.8-5.0 µg/L) |
37 |
252 |
|
0.95 |
0.58-1.56 |
|
1.02 |
0.57-1.82 |
|
1.05 |
0.56-1.95 |
|
|
Upper tertile (>5.0 µg/L) |
26 |
218 |
|
0.77 |
0.45-1.33 |
|
0.82 |
0.43-1.57 |
|
0.86 |
0.40-1.84 |
|
Abbreviations: CI, confidence interval; No., number; OR, odds ratios; ref, reference group |
||||||||||||
|
aAdjusted for sex, age, ethnicity, education, body mass index, serum cotinine, and current use of hypertension medications. |
||||||||||||
|
bAdjusted for sex, age, ethnicity, education, body mass index, serum cotinine, current use of hypertension medications and urine creatinine (in ug/L). |
||||||||||||
|
cThe detection limit was used rather than the 20th percentile since > 20% of people had arsenobetaine concentrations below detection. |
||||||||||||
|
dThis group contains fewer than 159 subjects (the 20th percentile) since a large number of subjects had DMA levels of 2 µg/L and were assigned to the 20-80th percentile group. |
||||||||||||
|
50 University Hall MC7360 ~ Berkeley, CA 94720-7360 Telephone: 510/843-1736 E-mail: asrg@berkeley.edu |